Featured Pharma Online Editorial

1. Why Early Evaluation Of Process Parameters Matters In OSD Scale-Up 10/26/2026

   For oral solid dose (OSD) manufacturers, technology transfer often becomes an exercise in managing uncertainty. Differences in equipment, blending conditions, material properties, and tooling design can introduce challenges that may not become apparent until later-stage development or even commercial scale-up.

2. Printing A New Path To The Brain: 3D Buccal Nanofilms For CNS Lymphoma 10/19/2026

   Though methotrexate is the most effective therapeutic against primary central nervous system (CNS) lymphoma, it can cause toxicity issues at therapeutic concentrations. Aditi Suchitkumar Satoskar and her research team at Mercer University sought to look for alternatives, investigating a noninvasive approach that combines methotrexate-loaded bovine serum albumin nanoparticles, an RVG-derived brain-targeting peptide, and a 3D-printed buccal film.

3. Capturing Tablet Disintegration for Improved OSD Development 10/15/2026

   Closed-loop laboratory automation promises to make oral solid dosage form development faster and more efficient, but the behavior of powders, tablets and dissolution processes remains difficult to predict.

4. Are You Falling Behind On Intelligent Pharmaceutical Manufacturing? 10/2/2026

   With a focus on small molecule drug product manufacture, let's take a closer look at the efficiencies gained through closed-loop control, PAT, digital twins, and more.

5. Why Supplier Diversification Doesn't Ensure Supply Safety 9/15/2026

   Recent events show supplier count to be an incomplete measure of resilience. The more useful question is whether separate supply arrangements remain independent when a critical material, capability, or route fails.

6. Can U.S. Policy Bring Generic Drug Manufacturing Back Home? 8/25/2026

   Generic medicines imported into the U.S. were not subject to the recently imposed tariffs on imported pharmaceuticals, but President Trump posted in July that this could change within two years.

7. July Update — U.S. Generic Drug Tariffs: Implications For Pharma And Outsourcing 8/7/2026

   Mathini Ilancheran updates us on how delayed U.S. tariffs on generic drug imports could reshape supply, sourcing, and trial planning.

8. 6 Reasons Pharma Manufacturing Has Eyes On Puerto Rico 8/1/2026

   Several advantages explain why Puerto Rico continues to attract pharma investment, especially as manufacturers reassess supply chain risk and look for options closer to the U.S. mainland.

9. Bayer Adds A Spine To Modularity For Scale Without Disruption 7/16/2026

   Modular facility concepts offer a different path, giving manufacturers the ability to expand capacity stepwise, standardize core infrastructure, and adapt production environments as product portfolios evolve

10. Engineering Challenges In Designing Pharmaceutical Isolators 7/7/2026

    Designing pharmaceutical barrier systems requires balancing strict cleanliness with practical engineering. Explore key factors for optimizing airflow and ergonomics.